FDA Approved: LANREOTIDE ACETATE — Original Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s original application for lanreotide acetate (lanreotide) to treat acromegaly and gastroenteropancreatic neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Gastroenteropancreatic Neuroendocrine Tumor

Drugs mentioned

• LANREOTIDE ACETATE (Lanreotide acetate)

Snippet

ORIG AP for LANREOTIDE ACETATE (LANREOTIDE ACETATE)